Learn how breathing strategies and cold immersion techniques developed by Wim Hof directly impact the autonomic and ...

The treatment and delivery method were also approved for adult patients with chronic inflammatory demyelinating polyneuropathy, an autoimmune disorder that causes progressive weakness and sensory ...

a drug used to treat autoimmune disorder that causes patchy hair loss. Sun Pharma has been locked in a patent infringement litigation with Incyte Corporation over LEQSELVI (deuruxolitinib).

Dilly, 29, also from London, has Hashimoto’s thyroiditis, an autoimmune disorder where the ... biologically mediated through brain activity, autonomic nervous system changes, and hormonal ...

Credit: Dalin Ou via Getty Images. US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune diseases and ...

Immunology continues to be one of the most active areas for drug research as the field aims to bring patients new ways to eliminate the antibodies driving autoimmune disease, but in a manner that ...

The latest biotech to roll out of Third Rock Ventures is working on Fc-based therapeutics it hopes could offer new treatment options to patients with autoimmune disorders like Graves' disease.

A scrap­py team of drug de­vel­op­ers has come to­geth­er to cre­ate new med­i­cines for pa­tients with au­toim­mune dis­eases and al­ler­gies. They’re go­ing af­ter the ...

- Series A financing co-led by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures CAMBRIDGE, Mass., April 08, 2025--(BUSINESS WIRE)--Merida Biosciences, a biotechnology company ...

Researchers analyzed 220,192 patients with primary dysautonomia and 220,192 matched individuals without the condition from the TriNetX database. The risk for SD at least 1 day after the diagnosis ...

A new biotech, Merida Biosciences, has launched with $121 million in the bank to advance a new class of precision treatments for autoimmune and allergic diseases. Merida’s therapies are “antibody-like ...

People who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles we use to blink, smile or even move our body around. Researchers have ...